You are here: University Home > APTITUDE > Web Randomisation

Study Coordinator Contact

Phone: +44 (0) 151 794 9773

APTITUDE Trial logo APTITUDE - A phase II trial of Tocilizumab in anti-TNF refractory patients with JIA associated uveitis

To access these pages you need to login.

If you do not have credentials to access this system please contact the trial coordinator email: or telephone +44 (0) 151 794 9773.


Forgotten password - Reset my password
Forgotten username - Contact the APTITUDE trial coordinator